Barclays analyst Warren Ackerman maintained a Hold rating on Haleon PLC on October 10 and set a price target of £3.80. The company’s shares closed last Friday at p338.50.Elevate Your Investing Strategy:...
In a report released on October 8, Olivier Nicolai from Goldman Sachs reiterated a Buy rating on Haleon PLC, with a price target of p440.00. The company’s shares closed last Friday at p338.50.Elevate...
In a report released yesterday, Rashad Kawan from Morgan Stanley maintained a Buy rating on Haleon PLC, with a price target of £4.00. The company’s shares closed today at p338.50.Elevate Your Investing...
Berenberg Bank analyst Bethan Davies maintained a Buy rating on Haleon PLC yesterday and set a price target of p507.00. The company’s shares closed yesterday at p339.80.Elevate Your Investing Strategy:...
Berenberg Bank analyst maintained a Buy rating on Haleon PLC Sponsored ADR yesterday and set a price target of $13.60. The company’s shares closed yesterday at $9.02.Elevate Your Investing Strategy:...
Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world’s #1 AI CRM, today announced that Haleon will leverage Salesforce...
In Wednesday’s unusual options activity, 78 call options expired in 100 days or more. Of those, you could buy 27 for $100 or less. The 27 make an excellent start to building an inexpensive portfolio...
The %Healthcare landscape is undergoing a significant transformation, driven by the convergence of %ArtificialIntelligence (AI), %DigitalHealth platforms, and value-based care. AI is reshaping how healthcare...
GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below. The stock has...
Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon itself for around $3.3 billion. Pfizer sold its 7.3% stake in Haleon, or approximately...